The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Inflammatory cortical demyelination in early multiple sclerosis.
Open accessAbstract
BACKGROUND: Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with long-standing, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. METHODS: We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56%) at the last follow-up visit (at a median of 3.5 years). RESULTS: Cortical demyelination was present in 53 patients (38%) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81% of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72% of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82%) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41%) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. CONCLUSIONS: In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This may well reflect the greater microglia and astrocyte activity in the white matter; pure cortical lesions in post-mortem tissues show little or no inflammation (Bo et al., 2004; Brink et al., 2005; van Horssen et al., 2007), although early lesions have been associated with prominent microglial activation (Lucchinetti et al., 2011).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Lucchinetti et al., 2011
In the citing paper
“Biopsies taken from early MS patients with cortical demyelination were more likely to have leptomeningeal inflammation, consisting of effector T cells and IgA B cells infiltrates, than those without cortical demyelination.”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Lucchinetti et al., 2011
In the citing paper
“The leptomeninges are now recognized as a key player in multiple sclerosis (MS), an inflammatory CNS autoimmune disorder characterized by axon demyelination”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Lucchinetti et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
Self-citationCortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citationMagliozzi, R., Howell, O. W., Vora, A., Serafini, B., Nicholas, R. S., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,486
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206
Cortical lesions in multiple sclerosis
Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
Flagged first, then by citations
Research works printed but not linked: 1
- Tardif CL, 2010, Med Image Comput Assist Interv, 13, 181
Cited by
Sorted by citations
Items 101–200 of 1,000
Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis
Zivadinov, R., Havrdová, E., Bergsland, N., Týblová, M., Hagemeier, J., Seidl, Z., Dwyer, M. G., Vaněčková, M., Krásenský, J., Carl, E. M., et al. (2013) · Radiology · doi:10.1148/radiol.13122424 · Cited by 158
Advanced MRI and staging of multiple sclerosis lesions
Absinta, M., Sati, P., & Reich, D. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.59 · Cited by 161
Clarner, T., Diederichs, F., Berger, K., Denecke, B., Gan, L., van der Valk, P., Beyer, C., Amor, S., & Kipp, M. (2012) · Glia · doi:10.1002/glia.22367 · Cited by 155
Liu, Y., Carlsson, R., Comabella, M., Wang, J., Kosicki, M., Carrión, B., Hasan, M., Wu, X., Montalbán, X., Dziegiel, M. H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3485 · Cited by 164
Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier
Spencer, J. I., Bell, J. S., & DeLuca, G. C. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316011 · Cited by 154
Microbial view of central nervous system autoimmunity
Berer, K., & Krishnamoorthy, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.007 · Cited by 153
Zivadinov, R., Jakimovski, D., Gandhi, S., Ahmed, R., Dwyer, M. G., Horáková, D., Weinstock‐Guttman, B., Benedict, R. R. H., Vaněčková, M., Barnett, M. H., et al. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1181543 · Cited by 149
Gardner, C., Magliozzi, R., Durrenberger, P. F., Howell, O. W., Rundle, J., & Reynolds, R. (2013) · Brain · doi:10.1093/brain/awt279 · Cited by 148
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
Oberwahrenbrock, T., Ringelstein, M., Jentschke, S., Deuschle, K., Klumbies, K., Bellmann–Strobl, J., Harmel, J., Ruprecht, K., Schippling, S., Hartung, H., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513489757 · Cited by 147
Kamma, E., Lasisi, W. O., Libner, C. D., Ng, H. S., & Plemel, J. R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02408-y · Cited by 157
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
Mallucci, G., Peruzzotti‐Jametti, L., Bernstock, J. D., & Pluchino, S. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.003 · Cited by 153
Multiple sclerosis: Lessons from molecular neuropathology
Lassmann, H. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.003 · Cited by 142
Self-citationUpdating the mild encephalitis hypothesis of schizophrenia
Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 146
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Lodygin, D., Hermann, M., Schweingruber, N., Flügel-Koch, C., Watanabe, T., Schlosser, C., Merlini, A., Körner, H., Chang, H.-F., Fischer, H. J., et al. (2019) · Nature · doi:10.1038/s41586-019-0964-2 · Cited by 140
Meningeal inflammation and cortical demyelination in acute multiple sclerosis
Bevan, R. J., Evans, R., Griffiths, L., Watkins, L. M., Rees, M. I., Magliozzi, R., Allen, I. V., McDonnell, G. V., Kee, R., Naughton, M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25365 · Cited by 147
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138
Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions
Popescu, B. F. G., Frischer, J. M., Webb, S. M., Tham, M., Adiele, R. C., Robinson, C. A., Fitz‐Gibbon, P. D., Weigand, S. D., Metz, I., Nehzati, S., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1696-8 · Cited by 138
Self-citationMultiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
Miljković, D. M., & Spasojević, I. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5068 · Cited by 143
Pathologic heterogeneity persists in early active multiple sclerosis lesions
Metz, I., Weigand, S. D., Popescu, B. F. G., Frischer, J. M., Parisi, J. E., Guo, Y. X., Lassmann, H., Brück, W., & Lucchinetti, C. F. (2014) · Annals of Neurology · doi:10.1002/ana.24163 · Cited by 135
Self-citationMagliozzi, R., Serafini, B., Rosicarelli, B., Chiappetta, G., Veroni, C., Reynolds, R., & Aloisi, F. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827bfc62 · Cited by 139
The role of microglial activation in disease progression
Correale, J. D. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514533230 · Cited by 133
Buschmann, J. P., Berger, K., Awad, H., Clarner, T., Beyer, C., & Kipp, M. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9773-x · Cited by 133
Magliozzi, R., Howell, O. W., Durrenberger, P. F., Aricò, E., James, R., Cruciani, C., Reeves, C., Roncaroli, F., Nicholas, R. S., & Reynolds, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1650-x · Cited by 131
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Margoni, M., Preziosa, P., Filippi, M., & Rocca, M. A. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10744-x · Cited by 135
Chronic inflammation in multiple sclerosis - seeing what was always there
Matthews, P. M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0240-y · Cited by 128
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS
Nielsen, A. S., Kinkel, R. P., Madigan, N. K., Tinelli, E., Benner, T., & Mainero, C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a08ce8 · Cited by 133
Three-step one-way model in terahertz biomedical detection
Peng, Y., Huang, J., Luo, J., Yang, Z., Wang, L., Wu, X., Zang, X., Chen, Y., Gu, M., Hu, Q., et al. (2021) · PhotoniX · doi:10.1186/s43074-021-00034-0 · Cited by 127
Reali, C., Magliozzi, R., Roncaroli, F., Nicholas, R. S., Howell, O. W., & Reynolds, R. (2020) · Brain Pathology · doi:10.1111/bpa.12841 · Cited by 129
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Martinꝉ, R., Sospedra, M., Rosito, M., & Engelhardt, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201646485 · Cited by 133
Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology
Kukanja, P., Langseth, C. M., Rubio Rodríguez-Kirby, L. A., Agirre, E., Zheng, C., Raman, A., Yokota, C., Avenel, C., Tiklová, K., Guerreiro-Cacais, A. O., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.030 · Cited by 124
Villabona-Rueda, A. F., Erice, C., Pardo, C. A., & Stins, M. F. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00405 · Cited by 130
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis
Paling, D., Solanky, B., Riemer, F., Tozer, D. J., Wheeler‐Kingshott, C. A. M. G., Kapoor, R., Golay, X., & Miller, D. H. (2013) · Brain · doi:10.1093/brain/awt149 · Cited by 123
Involvement of CD8+ T Cells in Multiple Sclerosis
Salou, M., Nicol, B., Garcia, A., & Laplaud, D. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00604 · Cited by 135
Astrocytes in multiple sclerosis
Ludwin, S. K., Rao, V. T. S., Moore, C. S., & Antel, J. P. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516643396 · Cited by 131
Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
Campbell, G. R., & Mahad, D. (2018) · FEBS Letters · doi:10.1002/1873-3468.13013 · Cited by 121
Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease
Derk, J., Jones, H. E., Como, C., Pawlikowski, B., & Siegenthaler, J. A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.703944 · Cited by 120
Righart, R., Biberacher, V., Jonkman, L. E., Klaver, R., Schmidt, P. J., Buck, D., Berthele, A., Kirschke, J. S., Zimmer, C., Hemmer, B., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25020 · Cited by 120
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis
Papadopoulou, A., Mueller‐Lenke, N., Naegelin, Y., Kalt, G., Bendfeldt, K., Küster, P., Stoecklin, M., Gass, A., Sprenger, T., Radue, E. W., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513475490 · Cited by 129
Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells
Sasaki, K., Bean, A., Shah, S., Schutten, E., Huseby, P. G., Peters, B., Shen, Z. T., Vanguri, V. K., Liggitt, D., & Huseby, E. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302911 · Cited by 118
NG2 cells (polydendrocytes): Listeners to the neural network with diverse properties
Hill, R., & Nishiyama, A. (2014) · Glia · doi:10.1002/glia.22664 · Cited by 125
Multiple Sclerosis Risk Factors and Pathogenesis
Nourbakhsh, B., & Mowry, E. M. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000725 · Cited by 126
Strosznajder, A. K., Wójtowicz, S., Jeżyna, M. J., Sun, G. Y., & Strosznajder, J. B. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08629-9 · Cited by 124
Highly active multiple sclerosis: An update
Díaz, C., Zarco, L. A., & Rivera, D. M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.01.039 · Cited by 123
Duffy, S. S., Lees, J. G., & Moalem‐Taylor, G. (2014) · Multiple Sclerosis International · doi:10.1155/2014/285245 · Cited by 118
Anti-CD20 therapy depletes activated myelin-specific CD8 + T cells in multiple sclerosis
Sabatino, J. J., Wilson, M. R., Calabresi, P. A., Hauser, S. L., Schneck, J. P., & Zamvil, S. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915309116 · Cited by 118
B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
Lisak, R. P., Nedelkoska, L., Benjamins, J. A., Schalk, D. L., Bealmear, B., Touil, H., Li, R., Muirhead, G., & Bar‐Or, A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.05.004 · Cited by 123
Impact of B cells to the pathophysiology of multiple sclerosis
Arneth, B. M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1517-1 · Cited by 118
Disturbed function of the blood–cerebrospinal fluid barrier aggravates neuro-inflammation
Kooij, G., Kopplin, K., Blasig, R., Stuiver, M., Koning, N., Goverse, G., van der Pol, S. M. A., Hof, B. V. H., Gollasch, M., Drexhage, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1227-1 · Cited by 113
Zivadinov, R., Ramasamy, D. P., Vaněčková, M., Gandhi, S., Chandra, A., Hagemeier, J., Bergsland, N., Polak, P. E., Benedict, R. H. B., Hojnacki, D. W., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516678083 · Cited by 112
Farina, G., Magliozzi, R., Pitteri, M., Reynolds, R., Rossi, S., Gajofatto, A., Benedetti, M. D., Facchiano, F., Monaco, S., & Calabrese, M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0812-y · Cited by 115
Remyelination alters the pattern of myelin in the cerebral cortex
Orthmann-Murphy, J., Call, C. L., Molina-Castro, G. C., Hsieh, Y. C., Rasband, M. N., Calabresi, P. A., & Bergles, D. E. (2020) · eLife · doi:10.7554/elife.56621 · Cited by 111
The formation of inflammatory demyelinated lesions in cerebral white matter
Maggi, P., Macri, S. M. C., Gaitán, M. I., Leibovitch, E., Wholer, J. E., Knight, H. L., Ellis, M., Wu, T., Silva, A. C., Massacesi, L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24242 · Cited by 110
Invited Review: From nose to gut – the role of the microbiome in neurological disease
Bell, J. S., Spencer, J. I., Yates, R. L., Yee, S. A., Jacobs, B. M., & DeLuca, G. C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12520 · Cited by 111
Grey matter damage in multiple sclerosis
Klaver, R., de Vries, H. E., Schenk, G. J., & Geurts, J. J. G. (2013) · Prion · doi:10.4161/pri.23499 · Cited by 114
DNA damage in the oligodendrocyte lineage and its role in brain aging
Tse, K.-H., & Herrup, K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.006 · Cited by 108
Tertiary Lymphoid Organs in Central Nervous System Autoimmunity
Mitsdoerffer, M., & Peters, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00451 · Cited by 110
Wekerle, H. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1281914 · Cited by 108
Pikor, N. B., Prat, A., Bar‐Or, A., & Gommerman, J. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00657 · Cited by 108
Howell, O. W., Schulz‐Trieglaff, E. K., Carassiti, D., Gentleman, S. M., Nicholas, R. S., Roncaroli, F., & Reynolds, R. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12199 · Cited by 112
Border-associated macrophages in the central nervous system
Sun, R., & Jiang, H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03059-x · Cited by 120
Therapies for multiple sclerosis: translational achievements and outstanding needs
Haghikia, A., Hohlfeld, R., Gold, R., & Fugger, L. H. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.004 · Cited by 105
Distinct roles of the meningeal layers in CNS autoimmunity
Merlini, A., Haberl, M., Strauß, J., Hildebrand, L., Genc, N., Franz, J., Chilov, D., Alitalo, K. K., Flügel‐Koch, C., Stadelmann, C., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01108-3 · Cited by 110
Neurons as targets for T cells in the nervous system
Liblau, R., Gonzalez‐Dunia, D., Wiendl, H., & Zipp, F. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.008 · Cited by 109
Cerebellar Dysfunction in Multiple Sclerosis
Wilkins, A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00312 · Cited by 104
The CNS Immune Landscape from the Viewpoint of a T Cell
Mundt, S., Greter, M., Flügel, A., & Becher, B. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.07.008 · Cited by 107
Neuroradiological evaluation of demyelinating disease
Tillema, J., & Pirko, I. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613478870 · Cited by 102
Optimizing therapy early in multiple sclerosis: An evidence-based view
Ziemssen, T., Stefano, N. D., Sormani, M. P., Wijmeersch, B. V., Wiendl, H., & Kieseier, B. C. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.07.007 · Cited by 103
Datta, G., Colasanti, A., Rabiner, E. A., Gunn, R. N., Malik, O., Ciccarelli, O., Nicholas, R. S., Vlierberghe, E. V., Hecke, W. V., Searle, G. E., et al. (2017) · Brain · doi:10.1093/brain/awx228 · Cited by 99
CNS-resident classical DCs play a critical role in CNS autoimmune disease
Giles, D. A., Duncker, P. C., Wilkinson, N. M., Washnock-Schmid, J. M., & Segal, B. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123708 · Cited by 99
Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action
Behrangi, N., Fischbach, F., & Kipp, M. (2019) · Cells · doi:10.3390/cells8010024 · Cited by 100
Khodanovich, M. Y., Sorokina, I. V., Glazacheva, V., Евгеньевич, А. А., Nemirovich-Danchenko, N. M., Romashchenko, A. V., Tolstikova, T. G., Mustafina, L. R., & Yarnykh, V. L. (2017) · Scientific Reports · doi:10.1038/srep46686 · Cited by 97
Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss
You, Y., Gupta, V., Li, J. C., Klistorner, A. I., & Graham, S. L. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0003 · Cited by 97
Pathology of Multiple Sclerosis
Kipp, M., van der Valk, P., & Amor, S. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661248 · Cited by 98
Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE
Beck, E., Sati, P., Sethi, V., Kober, T., Dewey, B. E., Bhargava, P., Nair, G., Cortese, I. C. M., & Reich, D. S. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5534 · Cited by 95
Magliozzi, R., Howell, O. W., Calabrese, M., & Reynolds, R. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00838-7 · Cited by 100
Treaba, C. A., Granberg, T., Sormani, M. P., Herranz, E., Ouellette, R., Louapre, C., Sloane, J. A., Kinkel, R. P., & Mainero, C. (2019) · Radiology · doi:10.1148/radiol.2019181719 · Cited by 93
Multiple Sclerosis Phenotypes as a Continuum
Vollmer, T. L., Nair, K. V., Williams, I. M., & Álvarez, E. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001045 · Cited by 100
Clinically feasible MTR is sensitive to cortical demyelination in MS
Chen, J. T.-H., Easley, K., Schneider, C., Nakamura, K., Kidd, G. J., Chang, A., Staugaitis, S. M., Fox, R. J., Fisher, E., Arnold, D. L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31827deb99 · Cited by 93
Kuerten, S., Schickel, A., Kerkloh, C., Recks, M. S., Addicks, K., Ruddle, N. H., & Lehmann, P. V. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1023-3 · Cited by 93
Brain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92
Immunology of neuromyelitis optica: a T cell-B cell collaboration
Mitsdoerffer, M., Kuchroo, V., & Korn, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12118 · Cited by 91
Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS
Longoni, G., Rocca, M. A., Pagani, E., Riccitelli, G. C., Colombo, B., Rodegher, M., Falini, A., Comı, G., & Filippi, M. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0665-9 · Cited by 93
Mecha, M., Carrillo-Salinas, F. J., Mestre, L., Feliú, A., & Guaza, C. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.11.003 · Cited by 93
Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex
Carassiti, D., Altmann, D. R., Petrova, N., Pakkenberg, B., Scaravilli, F., & Schmierer, K. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12405 · Cited by 91
Nakamura, K., Guizard, N., Fonov, V., Narayanan, S., Collins, D. L., & Arnold, D. L. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.10.015 · Cited by 89
The changing clinical course of multiple sclerosis: A matter of gray matter
Calabrese, M., Romualdi, C., Poretto, V., Favaretto, A., Morra, A., Rinaldi, F., Perini, P., & Gallo, P. (2013) · Annals of Neurology · doi:10.1002/ana.23882 · Cited by 95
The meninges: new therapeutic targets for multiple sclerosis
Russi, A. E., & Brown, M. A. (2014) · Translational research · doi:10.1016/j.trsl.2014.08.005 · Cited by 90
Jafari, M., Schumacher, A.-M., Snaidero, N., Gavilanes, E. M. U., Neziraj, T., Kocsis-Jutka, V., Engels, D., Jürgens, T., Wagner, I., Weidinger, J. D. F., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00780-7 · Cited by 92
Miyazaki, Y., Li, R., Rezk, A., Misirliyan, H., Moore, C. S., Farooqi, N., Solis, M., Galleguillos, L., de Faria, O., Dang, V. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105421 · Cited by 90
Resolving the clinico-radiological paradox in multiple sclerosis
Chard, D., & Trip, S. A. (2017) · F1000Research · doi:10.12688/f1000research.11932.1 · Cited by 87
Zurawski, J. D., Lassmann, H., & Bakshi, R. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4237 · Cited by 88
Self-citationEffector and regulatory B cells in Multiple Sclerosis
Staun-Ram, E., & Miller, A. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.04.014 · Cited by 90
Cacciaguerra, L., Morris, P. P., Tobin, W. O., Chen, J. J.-W., Banks, S. A., Elsbernd, P. M., Redenbaugh, V., Tillema, J., Montini, F., Sechi, E., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000206820 · Cited by 90
Self-citationDuma, C., Kopyov, O., Kopyov, A., Berman, M., Lander, E., Elam, M., Arata, M., Weiland, D., Cannell, R., Caraway, C., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04983-5 · Cited by 85
Pathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J. J. G., van der Valk, P., Drukarch, B., & van Dam, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12841 · Cited by 89
Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis
Yarnykh, V. L., Bowen, J. D., Samsonov, A. A., Repovic, P., Mayadev, A. S., Qian, P., Gangadharan, B., Keogh, B. P., Maravilla, K. R., & Henson, L. J. (2014) · Radiology · doi:10.1148/radiol.14140528 · Cited by 87
Guglielmetti, C., Najac, C., Didonna, A., der Linden, A. V., Ronen, S. M., & Chaumeil, M. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613345114 · Cited by 83
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis
Debernard, L., Melzer, T. R., van Stockum, S., Graham, C., Wheeler‐Kingshott, C. A. M. G., Dalrymple‐Alford, J. C., Miller, D. H., & Mason, D. F. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305612 · Cited by 83
Targets of therapy in progressive MS
Lassmann, H. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517729455 · Cited by 83
Self-citation
Metadata
- Authors
- Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., Weigand, S. D., Mandrekar, J., & Ransohoff, R. M.
- Affiliations
- Mayo Clinic (US)
- Cleveland Clinic Research (US)
- Medical University of Vienna (AT)
- Universitätsmedizin Göttingen (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-12-08
- Volume
- 365
- Issue
- 23
- Pages
- 2188-2197
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3282172
- OpenAlex
- W2113948549
- Cited by
- 1,103
- References
- 50
- Citations by year
- 2026: 37 · 2025: 44 · 2024: 69 · 2023: 70 · 2022: 68 · 2021: 104 · 2020: 75 · 2019: 83 · 2018: 64 · 2017: 72 · 2016: 75 · 2015: 84 · 2014: 89 · 2013: 100 · 2012: 67
- FWCI
- 58.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- National Multiple Sclerosis Society (RG3185-B-3)
- Multiple Sclerosis Society
- National Institutes of Health (P50NS38667)
- National Institute of Neurological Disorders and Stroke (P50NS38667, P50NS038667, R01NS049577)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- multiple sclerosis, cortical demyelination, inflammatory demyelination, meningeal inflammation, cortical lesions, early multiple sclerosis, white matter lesions, stereotactic biopsy, disease progression
- MeSH terms
- Biopsy, Cerebral Cortex, Humans, Inflammation, Multiple Sclerosis, Prevalence, Logistic Models, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
